These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[X]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
47-1169572
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification no.)
|
|
Title of each class
Common stock: Par value $.001
|
Trading Symbol(s)
AQMS
|
Name of each exchange on which registered
Nasdaq Capital Market
|
|
Large accelerated filer [ ]
|
|
Accelerated filer [X]
|
|
|
|
|
|
Non-accelerated filer [ ]
|
|
Smaller reporting company [X]
|
|
|
|
|
|
|
|
Emerging growth company [X]
|
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
September 30, 2019
|
|
December 31, 2018
|
||||
|
|
(unaudited)
|
|
(Note 2)
|
||||
|
ASSETS
|
|
|
|
||||
|
Current assets
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
15,541
|
|
|
$
|
20,892
|
|
|
Accounts receivable, net
|
1,714
|
|
|
725
|
|
||
|
Inventory, net
|
1,823
|
|
|
765
|
|
||
|
Prepaid expenses and other current assets
|
876
|
|
|
370
|
|
||
|
Total current assets
|
19,954
|
|
|
22,752
|
|
||
|
|
|
|
|
||||
|
Non-current assets
|
|
|
|
||||
|
Property and equipment, net
|
51,649
|
|
|
45,548
|
|
||
|
Intellectual property, net
|
1,044
|
|
|
1,271
|
|
||
|
Other assets
|
4,273
|
|
|
1,800
|
|
||
|
Total non-current assets
|
56,966
|
|
|
48,619
|
|
||
|
|
|
|
|
||||
|
Total assets
|
$
|
76,920
|
|
|
$
|
71,371
|
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
|
|
|
|
|
||||
|
Current liabilities
|
|
|
|
||||
|
Accounts payable
|
$
|
5,288
|
|
|
$
|
2,088
|
|
|
Accrued expenses
|
3,582
|
|
|
5,196
|
|
||
|
Lease liability, current portion
|
536
|
|
|
121
|
|
||
|
Deferred rent, current portion
|
—
|
|
|
8
|
|
||
|
Notes payable, current portion
|
277
|
|
|
311
|
|
||
|
Convertible note payable, current portion
|
—
|
|
|
4,075
|
|
||
|
Total current liabilities
|
9,683
|
|
|
11,799
|
|
||
|
|
|
|
|
||||
|
Deferred rent, non-current portion
|
—
|
|
|
27
|
|
||
|
Lease liability, non-current portion
|
1,005
|
|
|
110
|
|
||
|
Asset retirement obligation
|
779
|
|
|
745
|
|
||
|
Notes payable, non-current portion
|
8,488
|
|
|
8,600
|
|
||
|
Total liabilities
|
19,955
|
|
|
21,281
|
|
||
|
|
|
|
|
||||
|
Commitments and contingencies
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Stockholders’ equity
|
|
|
|
||||
|
Common stock; $0.001 par value; 100,000,000 shares authorized; 57,292,874 and 38,932,437 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively,
|
57
|
|
|
39
|
|
||
|
Additional paid-in capital
|
185,529
|
|
|
145,147
|
|
||
|
Accumulated deficit
|
(128,621
|
)
|
|
(95,096
|
)
|
||
|
Total stockholders’ equity
|
56,965
|
|
|
50,090
|
|
||
|
|
|
|
|
||||
|
Total liabilities and stockholders’ equity
|
$
|
76,920
|
|
|
$
|
71,371
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Product sales
|
$
|
2,361
|
|
|
$
|
1,169
|
|
|
$
|
4,281
|
|
|
$
|
3,378
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Operating cost and expense
|
|
|
|
|
|
|
|
||||||||
|
Cost of product sales
|
8,231
|
|
|
6,453
|
|
|
20,097
|
|
|
16,489
|
|
||||
|
Research and development cost
|
282
|
|
|
967
|
|
|
1,240
|
|
|
3,645
|
|
||||
|
General and administrative expense
|
5,107
|
|
|
2,174
|
|
|
13,458
|
|
|
7,862
|
|
||||
|
Total operating expense
|
13,620
|
|
|
9,594
|
|
|
34,795
|
|
|
27,996
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Loss from operations
|
(11,259
|
)
|
|
(8,425
|
)
|
|
(30,514
|
)
|
|
(24,618
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Other income and (expense)
|
|
|
|
|
|
|
|
||||||||
|
Interest expense
|
(142
|
)
|
|
(919
|
)
|
|
(3,234
|
)
|
|
(2,225
|
)
|
||||
|
Interest and other income
|
85
|
|
|
81
|
|
|
225
|
|
|
123
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Total other expense, net
|
(57
|
)
|
|
(838
|
)
|
|
(3,009
|
)
|
|
(2,102
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Loss before income tax expense
|
(11,316
|
)
|
|
(9,263
|
)
|
|
(33,523
|
)
|
|
(26,720
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Income tax expense
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
(2
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Net loss
|
$
|
(11,316
|
)
|
|
$
|
(9,263
|
)
|
|
$
|
(33,525
|
)
|
|
$
|
(26,722
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Weighted average shares outstanding, basic and diluted
|
57,053,982
|
|
|
38,779,710
|
|
|
50,491,786
|
|
|
32,553,939
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Basic and diluted net loss per share
|
$
|
(0.20
|
)
|
|
$
|
(0.24
|
)
|
|
$
|
(0.66
|
)
|
|
$
|
(0.82
|
)
|
|
|
|
|
|
|
|
Additional Paid-in Capital
|
|
Accumulated Deficit
|
|
Total Stockholders' Equity (Deficit)
|
|||||||||
|
|
|
Common Stock
|
|
|
|
||||||||||||||
|
|
|
Shares
|
|
Amount
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Balances, June 30, 2019
|
|
56,889,876
|
|
|
$
|
57
|
|
|
$
|
181,863
|
|
|
$
|
(117,305
|
)
|
|
$
|
64,615
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
901
|
|
|
—
|
|
|
901
|
|
||||
|
Warrants related to Veolia agreement
|
|
—
|
|
|
—
|
|
|
1,734
|
|
|
—
|
|
|
1,734
|
|
||||
|
Common stock issued upon RSU vesting
|
|
91,319
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Common stock issued for consulting services
|
|
311,679
|
|
|
—
|
|
|
1,031
|
|
|
—
|
|
|
1,031
|
|
||||
|
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(11,316
|
)
|
|
(11,316
|
)
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Balances, September 30, 2019
|
|
57,292,874
|
|
|
$
|
57
|
|
|
$
|
185,529
|
|
|
$
|
(128,621
|
)
|
|
$
|
56,965
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Balances, December 31, 2018
|
|
38,932,437
|
|
|
$
|
39
|
|
|
$
|
145,147
|
|
|
$
|
(95,096
|
)
|
|
$
|
50,090
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
2,899
|
|
|
—
|
|
|
2,899
|
|
||||
|
Warrants related to Veolia agreement
|
|
—
|
|
|
—
|
|
|
4,046
|
|
|
—
|
|
|
4,046
|
|
||||
|
Common stock issued upon RSU vesting
|
|
448,487
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Common stock issued for consulting services
|
|
1,736,950
|
|
|
2
|
|
|
4,073
|
|
|
—
|
|
|
4,075
|
|
||||
|
Common stock issued in January 2019 public offering, net of $739 offering costs
|
|
5,175,000
|
|
|
5
|
|
|
9,058
|
|
|
—
|
|
|
9,063
|
|
||||
|
Common stock issued in May 2019 public offering, net of $1,683 offering costs
|
|
11,000,000
|
|
|
11
|
|
|
20,306
|
|
|
—
|
|
|
20,317
|
|
||||
|
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(33,525
|
)
|
|
(33,525
|
)
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Balances, September 30, 2019
|
|
57,292,874
|
|
|
$
|
57
|
|
|
$
|
185,529
|
|
|
$
|
(128,621
|
)
|
|
$
|
56,965
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Balances, June 30, 2018
|
|
38,779,710
|
|
|
$
|
39
|
|
|
$
|
144,016
|
|
|
$
|
(72,301
|
)
|
|
$
|
71,754
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
361
|
|
|
—
|
|
|
361
|
|
||||
|
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,263
|
)
|
|
(9,263
|
)
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Balances, September 30, 2018
|
|
38,779,710
|
|
|
$
|
39
|
|
|
$
|
144,377
|
|
|
$
|
(81,564
|
)
|
|
$
|
62,852
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Balances, December 31, 2017
|
|
27,554,076
|
|
|
$
|
27
|
|
|
$
|
113,780
|
|
|
$
|
(54,842
|
)
|
|
$
|
58,965
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
853
|
|
|
—
|
|
|
853
|
|
||||
|
Common stock issued under Officers and Directors Purchase Plan
|
|
2,034
|
|
|
—
|
|
|
4
|
|
|
—
|
|
|
4
|
|
||||
|
Common stock issued upon RSU vesting
|
|
65,600
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Common stock issued in overallotment related to December 2017 public offering, net of $10 transaction cost
|
|
1,072,500
|
|
|
2
|
|
|
2,101
|
|
|
—
|
|
|
2,103
|
|
||||
|
Common stock issued in June 2018 public offering, net of $2,096 offering costs
|
|
10,085,500
|
|
|
10
|
|
|
26,637
|
|
|
—
|
|
|
26,647
|
|
||||
|
Modification of Interstate Battery warrant #1
|
|
—
|
|
|
—
|
|
|
1,002
|
|
|
—
|
|
|
1,002
|
|
||||
|
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(26,722
|
)
|
|
(26,722
|
)
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Balances, September 30, 2018
|
|
38,779,710
|
|
|
$
|
39
|
|
|
$
|
144,377
|
|
|
$
|
(81,564
|
)
|
|
$
|
62,852
|
|
|
|
Nine Months Ended September 30,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net loss
|
$
|
(33,525
|
)
|
|
$
|
(26,722
|
)
|
|
Reconciliation of net loss to net cash used in operating activities
|
|
|
|
|
|
||
|
Depreciation
|
2,987
|
|
|
2,354
|
|
||
|
Amortization of intellectual property
|
137
|
|
|
143
|
|
||
|
Accretion of asset retirement obligation
|
34
|
|
|
32
|
|
||
|
Fair value of warrant modification, net
|
—
|
|
|
402
|
|
||
|
Fair value of common stock issued for consulting services
|
4,075
|
|
|
—
|
|
||
|
Stock-based compensation
|
2,899
|
|
|
853
|
|
||
|
Warrant expense
|
4,046
|
|
|
—
|
|
||
|
Amortization of debt discount
|
—
|
|
|
1,152
|
|
||
|
Amortization of deferred financing costs
|
47
|
|
|
64
|
|
||
|
Non-cash convertible note interest expense
|
2,556
|
|
|
509
|
|
||
|
Non-cash interest expense
|
95
|
|
|
—
|
|
||
|
Loss on disposal of Ebonex asset
|
90
|
|
|
—
|
|
||
|
Loss on disposal of equipment
|
79
|
|
|
10
|
|
||
|
Inventory adjustment
|
—
|
|
|
179
|
|
||
|
Changes in operating assets and liabilities
|
|
|
|
|
|
||
|
Accounts receivable
|
(988
|
)
|
|
21
|
|
||
|
Inventory
|
(1,058
|
)
|
|
(29
|
)
|
||
|
Prepaid expenses and other current assets
|
(507
|
)
|
|
448
|
|
||
|
Accounts payable
|
2,763
|
|
|
483
|
|
||
|
Accrued expenses
|
(1,914
|
)
|
|
827
|
|
||
|
Deferred rent
|
(35
|
)
|
|
(116
|
)
|
||
|
Other assets and liabilities
|
(372
|
)
|
|
—
|
|
||
|
Net cash used in operating activities
|
(18,591
|
)
|
|
(19,390
|
)
|
||
|
|
|
|
|
|
|
||
|
Cash flows from investing activities:
|
|
|
|
|
|
||
|
Purchases of property and equipment
|
(8,146
|
)
|
|
(3,057
|
)
|
||
|
Equipment deposits and other assets
|
(1,122
|
)
|
|
(10
|
)
|
||
|
Net cash used in investing activities
|
(9,268
|
)
|
|
(3,067
|
)
|
||
|
|
|
|
|
|
|
||
|
Cash flows from financing activities:
|
|
|
|
|
|
||
|
Proceeds from issuance of common stock, net of transaction costs
|
29,380
|
|
|
28,754
|
|
||
|
Payments on notes payable
|
(221
|
)
|
|
(206
|
)
|
||
|
Payments on finance leases
|
—
|
|
|
(112
|
)
|
||
|
Payments on convertible note
|
(6,651
|
)
|
|
—
|
|
||
|
Net cash provided by financing activities
|
22,508
|
|
|
28,436
|
|
||
|
|
|
|
|
|
|
||
|
Net decrease in cash and cash equivalents
|
(5,351
|
)
|
|
5,979
|
|
||
|
Cash and cash equivalents at beginning of period
|
20,892
|
|
|
22,793
|
|
||
|
|
|
|
|
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
15,541
|
|
|
$
|
28,772
|
|
|
|
Nine Months Ended September 30,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Supplemental disclosure of cash flows information
|
|
|
|
||||
|
Cash paid for income taxes
|
$
|
2
|
|
|
$
|
2
|
|
|
Cash paid for interest
|
$
|
454
|
|
|
$
|
465
|
|
|
|
|
|
|
||||
|
Supplemental disclosure of non-cash transactions
|
|
|
|
||||
|
Change in property and equipment resulting from change in accounts payable
|
$
|
(437
|
)
|
|
$
|
(45
|
)
|
|
Change in property and equipment resulting from change in accrued expenses
|
$
|
(259
|
)
|
|
$
|
(8
|
)
|
|
Change in equity resulting from change in accrued expenses
|
$
|
1,300
|
|
|
$
|
600
|
|
|
|
September 30,
|
||||
|
Excluded potentially dilutive securities (1):
|
2019
|
|
2018
|
||
|
|
|
|
|
||
|
Convertible note - principal
|
—
|
|
|
702,247
|
|
|
Options to purchase common stock
|
3,623,138
|
|
|
1,632,483
|
|
|
Unvested restricted stock units
|
403,154
|
|
|
107,723
|
|
|
Financing warrants to purchase common stock
|
4,839,197
|
|
|
2,340,828
|
|
|
Total potential dilutive securities
|
8,865,489
|
|
|
4,783,281
|
|
|
(1)
|
The number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations as required if the securities were dilutive.
|
|
|
Revenue
|
|
Revenue
|
|
Accounts Receivable
|
||||||||||||
|
|
Three months ended September 30,
|
|
Nine months ended September 30,
|
|
September 30,
2019 |
|
December 31,
2018 |
||||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Clarios (successor of Johnson Controls Battery Group, Inc.)
|
80
|
%
|
|
95
|
%
|
|
71
|
%
|
|
86
|
%
|
|
76
|
%
|
|
95
|
%
|
|
Ocean Partners USA, Inc.
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
10
|
%
|
|
—
|
%
|
|
—
|
%
|
|
P. Kay Metals
|
17
|
%
|
|
—
|
%
|
|
26
|
%
|
|
—
|
%
|
|
24
|
%
|
|
—
|
%
|
|
|
September 30, 2019
|
|
December 31, 2018
|
||||
|
|
|
|
|
||||
|
Finished goods
|
$
|
297
|
|
|
$
|
43
|
|
|
Work in process
|
465
|
|
|
164
|
|
||
|
Raw materials
|
1,061
|
|
|
558
|
|
||
|
Total inventory
|
$
|
1,823
|
|
|
$
|
765
|
|
|
Asset Class
|
|
Useful Life
(Years)
|
|
September 30,
2019 |
|
December 31,
2018 |
||||
|
|
|
|
|
|
|
|
||||
|
Operational equipment
|
|
3-10
|
|
$
|
21,461
|
|
|
$
|
15,926
|
|
|
Lab equipment
|
|
5
|
|
580
|
|
|
698
|
|
||
|
Computer equipment
|
|
3
|
|
221
|
|
|
201
|
|
||
|
Office furniture and equipment
|
|
3
|
|
353
|
|
|
336
|
|
||
|
Land
|
|
-
|
|
1,047
|
|
|
1,047
|
|
||
|
Building
|
|
39
|
|
24,867
|
|
|
24,820
|
|
||
|
Asset retirement cost
|
|
20
|
|
670
|
|
|
670
|
|
||
|
Equipment under construction
|
|
|
|
11,087
|
|
|
7,892
|
|
||
|
|
|
|
|
60,286
|
|
|
51,590
|
|
||
|
Less: accumulated depreciation
|
|
|
|
(8,637
|
)
|
|
(6,042
|
)
|
||
|
|
|
|
|
|
|
|
||||
|
Total property and equipment, net
|
|
|
|
$
|
51,649
|
|
|
$
|
45,548
|
|
|
|
|
December 31, 2018
|
||
|
|
|
|
||
|
Convertible note payable
|
|
$
|
5,000
|
|
|
Accrued interest
|
|
1,651
|
|
|
|
Deferred financing costs, net
|
|
(20
|
)
|
|
|
Note discount
|
|
(2,556
|
)
|
|
|
|
|
|
||
|
Less current portion
|
|
4,075
|
|
|
|
|
|
|
||
|
Convertible note payable, non-current portion
|
|
$
|
—
|
|
|
|
September 30,
2019 |
|
December 31,
2018 |
||||
|
|
|
|
|
||||
|
Notes payable, current portion
|
|
|
|
||||
|
Capital equipment leases
|
$
|
—
|
|
|
$
|
16
|
|
|
Green Bank, net of issuance costs
|
277
|
|
|
295
|
|
||
|
Total notes payable, current portion
|
$
|
277
|
|
|
$
|
311
|
|
|
|
|
|
|
||||
|
Notes payable, non-current portion
|
|
|
|
||||
|
Capital equipment leases
|
$
|
—
|
|
|
$
|
31
|
|
|
Green Bank, net of issuance costs
|
8,488
|
|
|
8,569
|
|
||
|
Total notes payable, non-current portion
|
$
|
8,488
|
|
|
$
|
8,600
|
|
|
|
Three months ended September 30, 2019
|
Nine months ended September 30, 2019
|
||||
|
Cash paid for operating lease liabilities
|
$
|
157
|
|
$
|
466
|
|
|
Operating lease cost
|
$
|
144
|
|
$
|
433
|
|
|
|
September 30, 2019
|
|
|
Weighted-average remaining lease term
|
2.5 Years
|
|
|
Weighted-average discount rate
|
9.66
|
%
|
|
|
|
||
|
Due in 12-month period ended September 30,
|
|
||
|
2020
|
$
|
638
|
|
|
2021
|
$
|
656
|
|
|
2022
|
$
|
393
|
|
|
|
$
|
1,687
|
|
|
Less imputed interest
|
$
|
(179
|
)
|
|
Total lease liabilities
|
$
|
1,508
|
|
|
|
|
||
|
Current operating lease liabilities
|
$
|
530
|
|
|
Non-current operating lease liabilities
|
$
|
978
|
|
|
|
$
|
1,508
|
|
|
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||||||||
|
|
2019
|
|
2018
|
2019
|
|
2018
|
||||||||
|
Cost of product sales
|
$
|
32
|
|
|
$
|
35
|
|
$
|
124
|
|
|
$
|
132
|
|
|
Research and development cost
|
34
|
|
|
26
|
|
168
|
|
|
215
|
|
||||
|
General and administrative expense
|
835
|
|
|
300
|
|
2,607
|
|
|
506
|
|
||||
|
Total
|
$
|
901
|
|
|
$
|
361
|
|
$
|
2,899
|
|
|
$
|
853
|
|
|
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||||
|
|
2019
|
|
2018
|
2019
|
|
2018
|
||||
|
|
|
|
|
|
|
|
||||
|
Expected stock volatility
|
86.2% - 86.5%
|
|
|
78.0% - 79.3%
|
|
82.3% - 87.5%
|
|
|
78.0% - 86.3%
|
|
|
Risk free interest rate
|
1.7% - 1.8%
|
|
|
2.6% - 2.9%
|
|
1.7% - 2.6%
|
|
|
2.1% - 2.9%
|
|
|
Expected years until exercise
|
3.5
|
|
|
3.5
|
|
1.0 - 4.0
|
|
|
2.5 - 3.5
|
|
|
Dividend yield
|
0
|
%
|
|
0
|
%
|
0
|
%
|
|
0
|
%
|
|
|
Three months ended September 30,
|
|
Nine months ended September 30,
|
||||||||||||||||||||||||||
|
|
2019
|
|
2018
|
|
Favorable
(Unfavorable)
|
|
%
Change
|
|
2019
|
|
2018
|
|
Favorable
(Unfavorable)
|
|
%
Change
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Product sales
|
$
|
2,361
|
|
|
$
|
1,169
|
|
|
$
|
1,192
|
|
|
102.0
|
%
|
|
$
|
4,281
|
|
|
$
|
3,378
|
|
|
$
|
903
|
|
|
26.7
|
%
|
|
Cost of product sales
|
8,231
|
|
|
6,453
|
|
|
(1,778
|
)
|
|
27.6
|
%
|
|
20,097
|
|
|
16,489
|
|
|
(3,608
|
)
|
|
21.9
|
%
|
||||||
|
Research and development cost
|
282
|
|
|
967
|
|
|
685
|
|
|
(70.8
|
)%
|
|
1,240
|
|
|
3,645
|
|
|
2,405
|
|
|
(66.0
|
)%
|
||||||
|
General and administrative expense
|
5,107
|
|
|
2,174
|
|
|
(2,933
|
)
|
|
134.9
|
%
|
|
13,458
|
|
|
7,862
|
|
|
(5,596
|
)
|
|
71.2
|
%
|
||||||
|
Total operating expense
|
$
|
13,620
|
|
|
$
|
9,594
|
|
|
$
|
(4,026
|
)
|
|
42.0
|
%
|
|
$
|
34,795
|
|
|
$
|
27,996
|
|
|
$
|
(6,799
|
)
|
|
24.3
|
%
|
|
|
Three months ended September 30,
|
|
Nine months ended September 30,
|
||||||||||||||||||||||||||
|
|
2019
|
|
2018
|
|
Favorable
(Unfavorable)
|
|
%
Change
|
|
2019
|
|
2018
|
|
Favorable
(Unfavorable)
|
|
%
Change
|
||||||||||||||
|
Other income and (expense)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Interest expense
|
$
|
(142
|
)
|
|
$
|
(919
|
)
|
|
$
|
777
|
|
|
84.5
|
%
|
|
$
|
(3,234
|
)
|
|
$
|
(2,225
|
)
|
|
$
|
(1,009
|
)
|
|
(45.3
|
)%
|
|
Interest and other income
|
$
|
85
|
|
|
$
|
81
|
|
|
$
|
4
|
|
|
4.9
|
%
|
|
$
|
225
|
|
|
$
|
123
|
|
|
$
|
102
|
|
|
82.9
|
%
|
|
|
Nine Months Ended September 30,
|
||||||
|
|
2019
|
|
2018
|
||||
|
|
|
|
|
||||
|
Net cash used in operating activities
|
$
|
(18,591
|
)
|
|
$
|
(19,390
|
)
|
|
Net cash used in investing activities
|
$
|
(9,268
|
)
|
|
$
|
(3,067
|
)
|
|
Net cash provided by financing activities
|
$
|
22,508
|
|
|
$
|
28,436
|
|
|
•
|
the timing and success of our plan of commercialization and the fact that we continue to experience delays in ramping up our LAB recycling operations at TRIC;
|
|
•
|
our ability to bring modules online and ramp-up production on a commercial scale;
|
|
•
|
our ability to profitably operate our AquaRefining process on a commercial scale;
|
|
•
|
our ability to realize the expected benefits of our strategic partnerships with Clarios and Veolia; and
|
|
•
|
our ability to procure LABs in sufficient quantities at competitive prices.
|
|
•
|
limit our flexibility in developing our business operations and planning for, or reacting to, changes in our business;
|
|
•
|
increase our vulnerability to, and reduce our flexibility to respond to, general adverse economic and industry conditions; and
|
|
•
|
place us at a competitive disadvantage as compared to our competitors that are not as highly leveraged.
|
|
•
|
our ability to acquire sufficient quantities of used LABs at competitive prices;
|
|
•
|
our ability to produce AquaRefined lead that is priced competitively with lead produced by traditional smelting;
|
|
•
|
our ability to produce AquaRefined lead on a commercial scale and at an adequate gross profit; and
|
|
•
|
our ability to sell our AquaRefined lead at prices and in quantities that provide an adequate net profit from operations.
|
|
•
|
increased cost of enforcing our intellectual property rights;
|
|
•
|
diminished ability to protect our intellectual property rights;
|
|
•
|
heightened price sensitivities from customers in emerging markets;
|
|
•
|
our ability to establish or contract for local manufacturing, support and service functions;
|
|
•
|
localization of our LABs and components, including translation into foreign languages and the associated expenses;
|
|
•
|
compliance with multiple, conflicting and changing governmental laws and regulations;
|
|
•
|
compliance with the Federal Corrupt Practices Act and other anti-corruption laws;
|
|
•
|
foreign currency fluctuations;
|
|
•
|
laws favoring local competitors;
|
|
•
|
weaker legal protections of contract terms, enforcement on collection of receivables and intellectual property rights and mechanisms for enforcing those rights;
|
|
•
|
market disruptions created by public health crises in regions outside the United States;
|
|
•
|
difficulties in staffing and managing foreign operations, including challenges presented by relationships with workers’ councils and labor unions;
|
|
•
|
issues related to differences in cultures and practices; and
|
|
•
|
changing regional economic, political and regulatory conditions.
|
|
•
|
not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act;
|
|
•
|
reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements;
|
|
•
|
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments; and
|
|
•
|
extended transition periods available for complying with new or revised accounting standards.
|
|
•
|
limit who may call stockholder meetings;
|
|
•
|
do not permit stockholders to act by written consent;
|
|
•
|
do not provide for cumulative voting rights;
|
|
•
|
establish an advance notice procedure for stockholders' proposals to be brought before an annual meeting, including proposed nominations of persons for election to our board of directors, and
|
|
•
|
provide that all vacancies may be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum.
|
|
Exhibit
No.
|
|
Description
|
|
Method of Filing
|
|
|
|
|
|
|
|
3.1
|
|
|
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on July 22, 2015.
|
|
|
|
|
|
|
|
|
3.2
|
|
|
Incorporated by reference from the Registrant’s Current Report on Form 8-K filed on September 27. 2018.
|
|
|
|
|
|
|
|
|
3.3
|
|
|
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on June 9, 2015.
|
|
|
|
|
|
|
|
|
3.4
|
|
|
Incorporated by reference from the Registrant’s Quarterly Report on Form 10Q filed on May 9, 2019
|
|
|
|
|
|
|
|
|
31.1
|
|
|
Filed electronically herewith
|
|
|
|
|
|
|
|
|
31.2
|
|
|
Filed electronically herewith
|
|
|
|
|
|
|
|
|
32.1
|
|
|
Filed electronically herewith
|
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
Filed electronically herewith
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
Filed electronically herewith
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
Filed electronically herewith
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
Filed electronically herewith
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
Filed electronically herewith
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
Filed electronically herewith
|
|
|
|
AQUA METALS, INC.
|
|
|
|
|
|
|
|
Date:
|
November 12, 2019
|
By:
|
/s/
Stephen Cotton
|
|
|
|
|
Stephen Cotton,
|
|
|
|
|
President, Chief Executive Officer and Director
(Principal Executive Officer)
|
|
|
|
|
|
|
Date:
|
November 12, 2019
|
By:
|
/s/ Judd Merrill
|
|
|
|
|
Judd Merrill,
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
(Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|